NDC 17856-0162 Phenobarbital With Belladonna Alkaloids

View Dosage, Usage, Ingredients, Routes, UNII

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
NDC Product Code:
17856-0162
Proprietary Name:
Phenobarbital With Belladonna Alkaloids
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Labeler Name: [5]
Atlantic Biologicals Corp.
Labeler Code:
17856
Start Marketing Date: [9]
05-21-2018
Listing Expiration Date: [11]
12-31-2019
Exclude Flag: [12]
I
Code Structure:
Code Navigator:

Product Characteristics

Color(s):
PURPLE (C48327)
Flavor(s):
GRAPE (C73391)

Product Packages

NDC Code 17856-0162-1

Package Description: 10 mL in 1 CUP, UNIT-DOSE

NDC Code 17856-0162-2

Package Description: 5 mL in 1 CUP, UNIT-DOSE

NDC Code 17856-0162-3

Package Description: 5 mL in 1 CUP, UNIT-DOSE

NDC Code 17856-0162-4

Package Description: 10 CUP, UNIT-DOSE in 1 BOX / 10 mL in 1 CUP, UNIT-DOSE

Product Details

What is NDC 17856-0162?

The NDC code 17856-0162 is assigned by the FDA to the product Phenobarbital With Belladonna Alkaloids which is product labeled by Atlantic Biologicals Corp.. The product's dosage form is . The product is distributed in 4 packages with assigned NDC codes 17856-0162-1 10 ml in 1 cup, unit-dose , 17856-0162-2 5 ml in 1 cup, unit-dose , 17856-0162-3 5 ml in 1 cup, unit-dose , 17856-0162-4 10 cup, unit-dose in 1 box / 10 ml in 1 cup, unit-dose. This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Phenobarbital With Belladonna Alkaloids?

Possibly effective for use as adjunctive therapy in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis. May also be useful as adjunctive therapy in the treatment of duodenal ulcer.IT HAS NOT BEEN SHOWN CONCLUSIVELY WHETHER ANTICHOLINERGIC/ANTISPASMODIC DRUGS AID IN THE HEALING OF A DUODENAL ULCER, DECREASE THE RATE OF RECURRENCES OR PREVENT COMPLICATIONS.

Which are Phenobarbital With Belladonna Alkaloids UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Phenobarbital With Belladonna Alkaloids Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Phenobarbital With Belladonna Alkaloids?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 1046787 - PHENobarbital 16.2 MG / hyoscyamine sulfate 0.1037 MG / atropine sulfate 0.0194 MG / scopolamine HBr 0.0065 MG in 5 mL Oral Solution
  • RxCUI: 1046787 - atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution
  • RxCUI: 1046787 - atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG per 5 ML Oral Solution

* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".